Tag: Luke Gill

Top Physician to Lead Cell-Based Therapy Panel at Clin Ops West

DURHAM, N.C., April 25, 2019 — Premier Research will moderate a panel on cell-based therapies on Tuesday, April 30, at the Clinical Operations in Oncology Trials West Coast meeting in Burlingame, Calif. Colin Hayward, the company’s chief medical officer, will lead a discussion about how researchers are overcoming the challenges inherent in creating cell-based cancer...

Clinical Research: Phase 1 - Phase 4

Boosting Immuno-Oncology’s Effectiveness Against Cancer

Immuno-oncology continues to be an exciting frontier in the fight against cancer. Researchers continue to develop drugs that allow the body to weaponize its own immune system against the growth of new tumors. Most uses of immunotherapies have been limited to cancers, like those in the lungs or pancreas, that produce a strong immune response. In his article...

Clinical Research: Phase 1 - Phase 4

Immuno-Oncology Drug Development: Opportunities Beyond Hope

Immuno-oncology drug development is complex and requires a thorough understanding of both the immune system’s role in cancer development and the unique challenges associated with evaluating therapeutic response. Over the past decade, immuno-oncology has become one of the most promising and fastest-growing areas of cancer research and drug development. Present-day advances in immuno-oncology can be...

Consulting

Starting a Novel Oncology Trial? A Lot Is at Stake, So Attend this February 24 Webinar

PHILADELPHIA, FEBRUARY 24, 2016 — There’s a lot to consider when investigating a novel and targeted oncology compound, and decisions you make early on can have profound and lasting implications. At a webinar on Wednesday, February 24, Premier Research will show how making sound decisions from the outset can improve your odds of long-term success....